scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1100258750 |
P356 | DOI | 10.1186/S12936-017-2167-3 |
P932 | PMC publication ID | 5759240 |
P698 | PubMed publication ID | 29310662 |
P8602 | University of Ghana Digital Collections (UGSpace) ID | 31454 |
P50 | author | Michael Theisen | Q58310143 |
Linda E Amoah | Q89114942 | ||
P2093 | author name string | Theisen, M. | |
Acquah, F.K. | |||
Amoah, L.E. | |||
Festus K Acquah | |||
Abagna, H.B. | |||
Aryee, N.A. | |||
Hamza B Abagna | |||
Nii A Aryee | |||
Ruth Okonu | |||
P2860 | cites work | Acquired immunity to malaria | Q24651173 |
Allelic dimorphism of the erythrocyte binding antigen-175 (eba-175) gene of Plasmodium falciparum and severe malaria: Significant association of the C-segment with fatal outcome in Ghanaian children | Q24806782 | ||
Structural and Functional Basis for Inhibition of Erythrocyte Invasion by Antibodies that Target Plasmodium falciparum EBA-175 | Q27678372 | ||
Different Regions of Plasmodium falciparum Erythrocyte-Binding Antigen 175 Induce Antibody Responses to Infection of Varied Efficacy. | Q30386145 | ||
Fitting Linear Mixed-Effects Models Using lme4 | Q30477923 | ||
A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies | Q33198902 | ||
Rapid assessment of malaria transmission using age-specific sero-conversion rates | Q33475618 | ||
The association between naturally acquired IgG subclass specific antibodies to the PfRH5 invasion complex and protection from Plasmodium falciparum malaria | Q37239883 | ||
What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity | Q37413044 | ||
Plasmodium falciparum genotype and gametocyte prevalence in children with uncomplicated malaria in coastal Ghana | Q37491136 | ||
Avidity of anti-malarial antibodies inversely related to transmission intensity at three sites in Uganda | Q37635335 | ||
Evidence for diversifying selection on erythrocyte-binding antigens of Plasmodium falciparum and P. vivax | Q38897395 | ||
A Plasmodium falciparum 48/45 single epitope R0.6C subunit protein elicits high levels of transmission blocking antibodies | Q39467691 | ||
A recombinant baculovirus-expressed Plasmodium falciparum receptor-binding domain of erythrocyte binding protein EBA-175 biologically mimics native protein. | Q39516438 | ||
A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages | Q39520295 | ||
Antibody responses to two new Lactococcus lactis-produced recombinant Pfs48/45 and Pfs230 proteins increase with age in malaria patients living in the Central Region of Ghana | Q40110842 | ||
Malaria: even more chronic in nature than previously thought; evidence for subpatent parasitaemia detectable by the polymerase chain reaction | Q43656144 | ||
A genus- and species-specific nested polymerase chain reaction malaria detection assay for epidemiologic studies | Q47848196 | ||
Long-term asymptomatic carriage of Plasmodium falciparum protects from malaria attacks: a prospective study among Senegalese children | Q47857941 | ||
Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen | Q47874795 | ||
Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia | Q47954510 | ||
Protection against clinical malaria by heterologous immunoglobulin G antibodies against malaria-infected erythrocyte variant surface antigens requires interaction with asymptomatic infections | Q47997112 | ||
Conservation of structure and function of the erythrocyte-binding domain of Plasmodium falciparum EBA-175. | Q48036387 | ||
Comparative analysis of Plasmodium reichenowi and P. falciparum erythrocyte-binding proteins reveals selection to maintain polymorphism in the erythrocyte-binding region of EBA-175. | Q48352895 | ||
EBA-175: an erythrocyte-binding ligand of Plasmodium falciparum. | Q53872636 | ||
Protein Identification and Analysis Tools on the ExPASy Server | Q56880448 | ||
Global Analysis of Gel Mobility of Proteins and Its Use in Target Identification | Q57228635 | ||
Improved method to calculate the antibody avidity index | Q58768134 | ||
Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum | Q33591313 | ||
Prevalence of Plasmodium falciparum and non-P. falciparum infections in a highland district in Ghana, and the influence of HIV and sickle cell disease | Q33601228 | ||
Boosting antibody responses to Plasmodium falciparum merozoite antigens in children with highly seasonal exposure to infection | Q33767397 | ||
Low-high season variation in Plasmodium falciparum erythrocyte binding antigen 175 (eba-175) allelic forms in malaria endemic area of Burkina Faso | Q33807008 | ||
Transgenic parasites stably expressing full-length Plasmodium falciparum circumsporozoite protein as a model for vaccine down-selection in mice using sterile protection as an endpoint | Q34036184 | ||
Target antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malaria | Q34301187 | ||
High avidity antibodies to full-length VAR2CSA correlate with absence of placental malaria | Q34326742 | ||
Humoral immune response to primary rubella virus infection | Q34429454 | ||
Subclass responses and their half-lives for antibodies against EBA175 and PfRh2 in naturally acquired immunity against Plasmodium falciparum malaria | Q34515219 | ||
Analysis of human antibodies to erythrocyte binding antigen 175 peptide 4 of Plasmodium falciparum | Q34537136 | ||
Imbalanced distribution of Plasmodium falciparum EBA-175 genotypes related to clinical status in children from Bakoumba, Gabon | Q34537144 | ||
Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in Kenya | Q34541443 | ||
Reticulocyte and erythrocyte binding-like proteins function cooperatively in invasion of human erythrocytes by malaria parasites | Q34739631 | ||
Evidence for erythrocyte-binding antigen 175 as a component of a ligand-blocking blood-stage malaria vaccine | Q34937705 | ||
Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response | Q34955461 | ||
Vaccination with conserved regions of erythrocyte-binding antigens induces neutralizing antibodies against multiple strains of Plasmodium falciparum | Q34988452 | ||
Seasonal changes in the antibody responses against Plasmodium falciparum merozoite surface antigens in areas of differing malaria endemicity in Indonesia | Q35062854 | ||
Evaluation of allelic forms of the erythrocyte binding antigen 175 (EBA-175) in Plasmodium falciparum field isolates from Brazilian endemic area | Q35111416 | ||
Targeted disruption of an erythrocyte binding antigen in Plasmodium falciparum is associated with a switch toward a sialic acid-independent pathway of invasion | Q35162176 | ||
Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli | Q35223977 | ||
Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria | Q35569042 | ||
Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008 | Q35877370 | ||
The complexities of malaria disease manifestations with a focus on asymptomatic malaria | Q35930447 | ||
Induction of biologically active antibodies in mice, rabbits, and monkeys by Plasmodium falciparum EBA-175 region II DNA vaccine. | Q35944174 | ||
Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria | Q36594057 | ||
Alterations of splenic architecture in malaria are induced independently of Toll-like receptors 2, 4, and 9 or MyD88 and may affect antibody affinity | Q36845116 | ||
Low prevalence of antibodies to preerythrocytic but not blood-stage Plasmodium falciparum antigens in an area of unstable malaria transmission compared to prevalence in an area of stable malaria transmission | Q36974401 | ||
Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development | Q36984161 | ||
Combined DNA extraction and antibody elution from filter papers for the assessment of malaria transmission intensity in epidemiological studies | Q37112876 | ||
Inhibitory humoral responses to the Plasmodium falciparum vaccine candidate EBA-175 are independent of the erythrocyte invasion pathway | Q37124750 | ||
Prevalence of G6PD deficiency and Plasmodium falciparum parasites in asymptomatic school children living in southern Ghana | Q37125793 | ||
Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure | Q37191417 | ||
Acquisition of Functional Antibodies That Block the Binding of Erythrocyte-Binding Antigen 175 and Protection Against Plasmodium falciparum Malaria in Children | Q37220749 | ||
P433 | issue | 1 | |
P921 | main subject | Plasmodium falciparum | Q311383 |
ELISA | Q3051059 | ||
malaria transmission | Q56928847 | ||
P304 | page(s) | 14 | |
P577 | publication date | 2018-01-01 | |
2018-01-08 | |||
P1433 | published in | Malaria Journal | Q15749954 |
P1476 | title | Assessment of the quality and quantity of naturally induced antibody responses to EBA175RIII-V in Ghanaian children living in two communities with varying malaria transmission patterns | |
P478 | volume | 17 |
Q59330088 | Characterization of anti-EBA175RIII-V in asymptomatic adults and children living in communities in the Greater Accra Region of Ghana with varying malaria transmission intensities |
Q91918114 | Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives |
Q92348258 | Diversity and immune responses against Plasmodium falciparum gametocytes in non-febrile school children living in Southern Ghana |
Q94481901 | Measuring antibody avidity to Plasmodium falciparum merozoite antigens using a multiplex immunoassay approach |
Q91611703 | Probing the composition of Plasmodium species contained in malaria infections in the Eastern region of Ghana |
Q58696333 | Seasonal variations in Plasmodium falciparum genetic diversity and multiplicity of infection in asymptomatic children living in southern Ghana |
Q89635451 | Stage‑specific Plasmodium falciparum immune responses in afebrile adults and children living in the Greater Accra Region of Ghana |
Search more.